Clinical Trial Update: Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update of VACdxr regimen for high-risk Ewing's sarcoma; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXRAZOXANE (DEXRAZOXANE)
• Doxorubicin (doxorubicin)
• Vincristine (vincristine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ewing's Sarcoma | Phase 2 | Status: TERMINATED | Results posted: 2020-01-29